Cargando…

Comprehensive Metabolic Profiling and Genome-wide Analysis Reveal Therapeutic Modalities for Hepatocellular Carcinoma

Understanding the details of metabolic reprogramming in hepatocellular carcinoma (HCC) is critical to improve stratification for therapy. Both multiomics analysis and cross-cohort validation were performed to investigate the metabolic dysregulation of 562 HCC patients from 4 cohorts. On the basis of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Feng, Li, Jia, Qi, Zhuoran, Zhang, Jian, Zhou, Bin, Yang, Biwei, Qin, Wenxing, Cui, Wenguo, Xia, Jinglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AAAS 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076022/ https://www.ncbi.nlm.nih.gov/pubmed/37040510 http://dx.doi.org/10.34133/research.0036

Ejemplares similares

Modeling cross‐talk of RNA modification enzymes reveals tumor microenvironment‐associated clinical significance and immunotherapy prediction in hepatobiliary malignancy
por: Qi, Feng, et al.
Publicado: (2023)

Serum LAG-3 Predicts Outcome and Treatment Response in Hepatocellular Carcinoma Patients With Transarterial Chemoembolization
por: Guo, Mengzhou, et al.
Publicado: (2021)

MT4‐MMP in tumor‐associated macrophages is linked to hepatocellular carcinoma aggressiveness and recurrence
por: Qi, Feng, et al.
Publicado: (2020)

Tumor Mutation Burden-Associated LINC00638/miR-4732-3p/ULBP1 Axis Promotes Immune Escape via PD-L1 in Hepatocellular Carcinoma
por: Qi, Feng, et al.
Publicado: (2021)

Sulfarotene, a synthetic retinoid, overcomes stemness and sorafenib resistance of hepatocellular carcinoma via suppressing SOS2-RAS pathway
por: Qi, Feng, et al.
Publicado: (2021)

Time-series clustering of cytokine expression after transarterial chemoembolization in patients with hepatocellular carcinoma
por: Qi, Feng, et al.
Publicado: (2020)

Loss of GABARAPL1 confers ferroptosis resistance to cancer stem‐like cells in hepatocellular carcinoma
por: Du, Xiaojing, et al.
Publicado: (2022)

Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma
por: Yang, Biwei, et al.
Publicado: (2018)

Comprehensive profiling of lysine acetylproteome analysis reveals diverse functions of lysine acetylation in common wheat
por: Zhang, Yumei, et al.
Publicado: (2016)

Expression and clinical significance of LAG-3, FGL1, PD-L1 and CD8(+)T cells in hepatocellular carcinoma using multiplex quantitative analysis
por: Guo, Mengzhou, et al.
Publicado: (2020)

A comprehensive genome‐wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma
por: Cui, Hongxia, et al.
Publicado: (2017)

Systematic profiling of a lipid metabolism‐derived signature guides risk‐stratification and therapeutic strategies in hepatocellular carcinoma
por: Zhu, Zhengyi, et al.
Publicado: (2023)

Protein convertase subtilisin/Kexin type 9 inhibits hepatocellular carcinoma growth by interacting with GSTP1 and suppressing the JNK signaling pathway
por: He, Mingyan, et al.
Publicado: (2022)

A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma
por: Sun, Suofeng, et al.
Publicado: (2019)

Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights
por: Shokoohian, Bahare, et al.
Publicado: (2021)

Comparative effectiveness of interventional therapeutic modalities for unresectable hepatocellular carcinoma: A systematic review and network meta-analysis
por: Chen, Xin-Long, et al.
Publicado: (2022)

TREM2 acts as a tumor suppressor in hepatocellular carcinoma by targeting the PI3K/Akt/β-catenin pathway
por: Tang, Wenqing, et al.
Publicado: (2019)

Comprehensive circular RNA expression profiling with associated ceRNA network reveals their therapeutic potential in cholesteatoma
por: Gao, Juanjuan, et al.
Publicado: (2020)

Roles of CXCL5 on migration and invasion of liver cancer cells
por: Xu, Xiaojing, et al.
Publicado: (2014)

Comprehensive review of diagnostic modalities for early chronic pancreatitis
por: Ge, Qi-Chao, et al.
Publicado: (2021)

Comprehensive Circular RNA Profiling Reveals That hsa_circ_0005075, a New Circular RNA Biomarker, Is Involved in Hepatocellular Crcinoma Development
por: Shang, Xingchen, et al.
Publicado: (2016)

Metabolite profile of COVID-19 revealed by UPLC-MS/MS-based widely targeted metabolomics
por: Liu, Jun, et al.
Publicado: (2022)

Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma
por: Jin, Yu, et al.
Publicado: (2019)

Comprehensive Dipeptide Analysis Revealed Cancer-Specific Profile in the Liver of Patients with Hepatocellular Carcinoma and Hepatitis
por: Ozawa, Hitoshi, et al.
Publicado: (2020)

Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors
por: Du, Xiaojing, et al.
Publicado: (2021)

RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma
por: Han, Zhiyi, et al.
Publicado: (2021)

HELLS modulates the stemness of intrahepatic cholangiocarcinoma through promoting senescence-associated secretory phenotype
por: Du, Xiaojing, et al.
Publicado: (2023)

Transcriptome and Lipidomic Analysis Suggests Lipid Metabolism Reprogramming and Upregulating SPHK1 Promotes Stemness in Pancreatic Ductal Adenocarcinoma Stem-like Cells
por: Xu, Jinzhi, et al.
Publicado: (2023)

Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs
por: Cheng, Lei, et al.
Publicado: (2016)

Comprehensive view on genetic features, therapeutic modalities and prognostic models in adult T-cell lymphoblastic lymphoma
por: Zou, Qihua, et al.
Publicado: (2022)

Nomograms predict survival outcome of Klatskin tumors patients
por: Qi, Feng, et al.
Publicado: (2020)

Prognostic Biomarkers on a Competitive Endogenous RNA Network Reveals Overall Survival in Triple-Negative Breast Cancer
por: Qin, Wenxing, et al.
Publicado: (2021)

Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas
por: Qi, Lin, et al.
Publicado: (2022)

The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma
por: Beppu, Toru, et al.
Publicado: (2017)

Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas
por: Zhang, Qi, et al.
Publicado: (2019)

Comprehensive molecular profiling of intrahepatic cholangiocarcinoma in the Chinese population and therapeutic experience
por: Wang, Longrong, et al.
Publicado: (2020)

Gastric antral vascular ectasia: the evolution of therapeutic modalities
por: Naidu, Harini, et al.
Publicado: (2014)

Genome-Wide Transcriptional Analysis Reveals Alternative Splicing Event Profiles in Hepatocellular Carcinoma and Their Prognostic Significance
por: Xiong, Yongfu, et al.
Publicado: (2020)

Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets
por: Luo, Huiyan, et al.
Publicado: (2023)

Genome-wide analysis of BpDof genes and the tolerance to drought stress in birch (Betula platyphylla)
por: Sun, Shilin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3k7lh88qsj2lqp9b2te4nddibt